Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg

Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg is a medicine authorised by Swissmedic under authorisation number 67674. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 16 April 2021 and the authorisation is valid without a time limit. ATC code M01AE51 places the medicine in the group Anti-inflammatory and antirheumatic products.

Dispensing category D
Authorisation number 67674
ATC M01AE51
Synthetic medicines

Authorisation data
Authorisation number	67674
Name	Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg
Full name	Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg, Filmtabletten
Authorisation holder	Bayer (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	D · No prescription, with advice
ATC code	M01AE51
First authorisation	16 April 2021
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg, Filmtabletten	D	16 April 2021

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	10	Tablette(n)	M01AE51	07.10.2.	D
2	12	Tablette(n)	M01AE51	07.10.2.	D
3	20	Tablette(n)	M01AE51	07.10.2.	D

Scroll the table sideways

Medicines in the same ATC group

Algifor Dolo Rhinogrippal 200 mg / 30 mgAuthorisation number 68264 · Verfora SA · ATC M01AE51D

Other medicines from this authorisation holder

Adempas 0.5 mgAuthorisation number 62903 · ATC C02KX05B Adempas junior 0.15 mg/mlAuthorisation number 69929 · ATC C02KX05B AleveAuthorisation number 53810 · ATC M01AE02D Alka-SeltzerAuthorisation number 8671 · ATC N02BA01D Ambelvist 0.1 mmol/ mlAuthorisation number 70405 · ATC V08CA13B Ambelvist 0.1 mmol/ mlAuthorisation number 70441 · ATC V08CA13B Ambelvist 0.1 mmol/ nlAuthorisation number 70440 · ATC V08CA13B AngeliqAuthorisation number 56275 · ATC G03FA17B

Frequently asked questions

Is Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg authorised in Switzerland?

Yes. Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg is authorised by Swissmedic under authorisation number 67674, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg have?

Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Pretufen Schnupfen und Erkältungsschmerzen 200 mg/30 mg?

The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.